Association of oxidative stress and DNA damage with grafting time in patients with multiple myeloma and lymphoma submitted to autologous hematopoietic stem cell transplantation

Abstract

The aim of the study was to investigate the association between oxidative stress and DNA damage with grafting time in patients submitted to autologous hematopoietic stem-cell transplantation (HSCT). The study included 37 patients submitted to autologous HSCT diagnosed with Multiple Myeloma (MM) and lymphoma (Hodgkin’s and non-Hodgkin’s). Biomarkers of oxidative stress and DNA damage index (DI) were performed at baseline (pre-CR) of the disease and during the conditioning regimen (CR), one day after the HSCT, ten days after HSCT and twenty days after HSCT, as well as in the control group consisting of 30 healthy individuals. The outcomes showed that both groups of patients had an hyperoxidative state with high DI when compared to baseline and to the control group and that the CR exacerbated this condition. However, after the follow-up period of the study, this picture was re-established to the baseline levels of each pathology. The study patients with MM showed a mean grafting time of 10.75 days (8 to 13 days), with 10.15 days (8 to 15 days) for the lymphoma patients. In patients with MM, there was a negative correlation between the grafting time and the basal levels of GPx (r = -0.54; p = 0.034), indicating that lower levels of this important enzyme are associated with a longer grafting time. For the DI, the correlation was a positive one (r = 0.529; p = 0.030). In the group with lymphoma, it was observed that the basal levels of NOx were positively correlated with grafting time (r = 0.4664, p = 0.032). The data indicate the potential of these biomarkers as predictors of toxicity and grafting time in patients with MM and Lymphomas submitted to autologous HSCT.

Evaluation of nutritional risk factors in hematopoietic stem cell transplantation-eligible patients

“…Oxidative DNA damage and longer time to engrafting were also reported in these patients. (27) Longer time to engrafting in response to oxidative stress is deleterious to patients, since the longer the hospital stay, the higher the risk of infections and other complications associated with individual morbidity and mortality. (1) Food intake in thought to be a significant factor in oxidative stress modulation.…”

Role of Gut Microbiota and Oxidative Stress in the Progression of Transplant-Related Complications following Hematopoietic Stem Cell Transplantation

“…Bone marrow stromal cells from patients receiving daunorubicin secreted higher levels of H 2 O 2 than that of healthy control participants, leading to the accumulation of DNA damage in cocultured hematopoietic cells [ 30 ]. Chemotherapeutic agents also disrupt redox balance by impairing antioxidant defense (e.g., superoxide dismutase and catalase) in human beings [ 31 ]. Plasma levels of vitamin C and catalase, which are powerful antioxidants for scavenging O 2- , H 2 O 2 , and OH − , decline after the application of melphalan and CTX-BCNU-etoposide conditioning regimens [ 32 ].…”

“…High catalase and α,α-diphenyl-β-picrylhydrazyl free radical scavenging activity Anticancer effect [118] Lactobacillus rhamnosus GG Ameliorates alcohol-induced intestinal oxidative stress, intestinal hyperpermeability, and liver injury in rodent models of alcohol steatohepatitis Alcoholic liver disease [119] 3 Oxidative Medicine and Cellular Longevity also disrupt redox balance by impairing antioxidant defense (e.g., superoxide dismutase and catalase) in human beings [31]. Plasma levels of vitamin C and catalase, which are powerful antioxidants for scavenging O 2-, H 2 O 2 , and OH -, decline after the application of melphalan and CTX-BCNU-etoposide conditioning regimens [32].…”

Animal models of chemotherapy-induced cognitive decline in preclinical drug development

“…Normal redox state plays a vital role in maintaining brain functions. A study conducted in the blood serum samples collected from patients with Hodgkin's lymphoma and multiple myeloma subjected to chemotherapy has decreased glutathione peroxidase, catalase, and superoxide dismutase which constitute an antioxidant defense system (Santos et al 2016). Disturbances in antioxidant mechanisms by chemotherapeutic agents result in the generation of free radicals in the hippocampus and frontal cortex involved in learning and memory.…”